NAGE News

Latest breaking news and updates for NAGE stock.

Track all markets on TradingView

Niagen Bioscience, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year Outlook

LOS ANGELES--(BUSINESS WIRE)---- $NAGE #Biotech--Niagen Bioscience, Inc. (NASDAQ:NAGE) today announced financial results for the second quarter of 2025. Second Quarter 2025 Financial Highlights Com...

What is the short‑term technical outlook for the ticker (resistance/support levels) following the news? What are the potential risks or challenges that could impede achieving the full-year outlook? How does NAGE’s growth trajectory compare to its main competitors in the NAD+ supplement space?
Earnings
17 days ago
Read more businesswire

Niagen Bioscience to Present at Canaccord Genuity’s 45th Annual Growth Conference

LOS ANGELES--(BUSINESS WIRE)---- $NAGE #Biotech--Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on ...

Could the conference provide insights into any upcoming M&A activity or strategic initiatives? What is the expected impact on the company's valuation based on projected growth in the NAD+ market? How might the market react to any changes in financial outlook or cash‑burn guidance discussed at the fireside chat?
Conference
19 days ago
Read more businesswire